Ashish Subhash Dandekar, a promoter of camlin fine sciences , has released a pledge on 4,000 equity shares of the company. The transaction was executed on July 24, 2026, and disclosed to stock exchanges on July 28, 2026. The release follows the repayment of borrowings by Camlin Fine Sciences Limited, reducing the promoter’s encumbered stake and signaling improved liquidity management within the group.

The disclosure was filed in compliance with Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The notice was submitted to the National Stock Exchange of India Ltd., BSE Limited, and the Company Secretary of Camlin Fine Sciences Ltd. The action reduces the number of pledged shares held in favor of LRSD Securities Private Limited.

Transaction Details

Prior to this event, Ashish Subhash Dandekar held 1,97,78,510 equity shares, representing 10.30% of the total share capital. Of these, 1,49,54,000 shares (7.78% of total share capital) were already encumbered. The release of 4,000 shares brings the total encumbered holding down to 1,49,50,000 shares, which continues to represent 7.78% of the total share capital due to the negligible impact on the percentage stake.

Promoter Holding Structure

| Holding Category | No. of Shares | % of Total Share Capital | | ---: | :--- | | Total Promoter Holding | 1,97,78,510 | 10.30% | | Pre-Event Encumbered Shares | 1,49,54,000 | 7.78% | | Shares Released | 4,000 | 0.00% | | Post-Event Encumbered Shares | 1,49,50,000 | 7.78% |

The release of pledge is a routine corporate action that typically indicates the settlement of underlying debt obligations. In this case, the source document explicitly attributes the release to the repayment of borrowings by the target company. This reduction in encumbrance improves the promoter’s collateral buffer and reduces potential dilution risks associated with forced liquidation of pledged shares.

What the Numbers Show

While the absolute number of shares released (4,000) is small relative to the promoter’s total holding of nearly 1.98 crore shares, the action confirms active debt servicing by Camlin Fine Sciences. The fact that the company itself repaid the borrowings leading to the pledge release suggests that the debt obligation was likely corporate rather than personal to the promoter, or that the company facilitated the repayment to unencumber the promoter’s holdings. The remaining encumbered stake of 1.49 crore shares remains significant, indicating that a substantial portion of the promoter’s equity is still leveraged.

Camlin Fine Sciences Limited has announced the scheduling of its 33rd Annual General Meeting (AGM) for August 11, 2026. The meeting will be conducted via video conferencing and other audio visual means, with the registered office serving as the deemed venue. The company has fixed Wednesday, August 5, 2026, as the cut-off date to determine shareholder eligibility for voting rights and participation in the meeting.

The notice for the AGM and the Annual Report for the financial year 2025-26 were dispatched electronically to members on July 18, 2026. In compliance with regulatory provisions, physical copies of these documents are not being sent to members. The reports are accessible on the company's website and the websites of the stock exchanges where the securities are listed.

Shareholders are entitled to exercise their voting rights through the remote e-voting system facilitated by the National Securities Depository Limited (NSDL). The remote e-voting period will commence at 9:00 a.m. IST on Saturday, August 8, 2026, and conclude at 5:00 p.m. IST on Monday, August 10, 2026. Members who have cast their votes remotely may attend the meeting but will not be eligible to vote again during the AGM.

M/s. JHR & Associates, Practicing Company Secretaries, has been appointed as the scrutinizer to oversee the e-voting process. The company has also provided contact details for grievances related to the electronic voting facility. Documents referred to in the AGM notice are available for inspection at the company's registered office during working hours until the date of the meeting.

Key Meeting Dates